CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

28 hedge funds and large institutions have $56.7M invested in Cymabay Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.45M
2 +$2.87M
3 +$2.6M
4
Morgan Stanley
Morgan Stanley
New York
+$477K
5
SIM
Spark Investment Management
New York
+$417K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.07M
2
$7.26M
3
$6.92M
4
$6.37M
5
$5.54M
6
$5.22M
7
$4.05M
8
$3.46M
9
$2.2M
10
$1.63M
11
$1.09M
12
$692K
13
$610K
14
$417K
15
$374K
16
$339K
17
$211K
18
$183K
19
$150K
20
$138K
21
$138K
22
$138K
23
$127K
24
$125K
25
$115K